2 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Recurrent Pregnancy Loss: new trials by email Literature Review of Recurrent Pregnancy Loss trials Research Report on Recurrent Pregnancy Loss
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells Mesenchymal stem cells capable of differentiation in the endometrial-decidual direction, Standard treatment according to the clinical protocols - Recurrent Pregnancy Loss | Phase 1 / Phase 2 | Unknown | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 20 | 2022-11-01 | 2022-08-29 |
| Hydroxychloroquine in Unexplained Recurrent Pregnancy Loss Hydroxychloroquine - Recurrent Pregnancy Loss | Phase 1 | Unknown | Ain Shams University | 70 | 2022-03-01 | 2022-02-14 |
Heparin, Low-Molecular-Weight (1) · Hydroxychloroquine (1)
Ain Shams University (1) · Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus (1)
Belarus (1)
PMID 10632428, PMID 19439078, PMID 21112094, PMID 21718553, PMID 21871597, PMID 22002012, PMID 23942472, PMID 24581729, PMID 24995856, PMID 25653897, PMID 25681385, PMID 26371706, PMID 27100512, PMID 9344498